BioCentury
ARTICLE | Clinical News

Lidocaine vaginal gel: Phase I data

July 18, 2016 7:00 AM UTC

Data from a pair of double-blind, placebo-controlled, Mexican Phase I trials in 42 healthy women each showed that single and once-daily doses of COL-1077 for 4 days were well tolerated with no serious...